Primary immunodeficiency diseases: Dissectors of the immune system

Immunological Reviews

Volumn 185, Issue , 2002, Pages 206-219

  Buckley, Rebecca H ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; CD45 ANTIGEN; CYTOKINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN M; INTERLEUKIN 7 RECEPTOR; JANUS KINASE; RECOMBINASE;

ALPHA CHAIN; ARTERMIS GENE; CELL ASSAY; CLINICAL TRIAL; COMBINED IMMUNODEFICIENCY; DISEASE SEVERITY; ENZYME DEFICIENCY; GENE; GENE THERAPY; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNE DEFICIENCY; IMMUNE SYSTEM; IMMUNITY; MEDICAL LITERATURE; MEDICAL RESEARCH; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TIME; X CHROMOSOME LINKED DISORDER;

ALLERGY AND IMMUNOLOGY; FEMALE; GENE THERAPY; HISTORY, 20TH CENTURY; HUMANS; IMMUNE SYSTEM; IMMUNOLOGIC DEFICIENCY SYNDROMES; JOB'S SYNDROME; MALE; SEVERE COMBINED IMMUNODEFICIENCY;

EID: 0036630392     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-065X.2002.18517.x     Document Type: Review

References (127)

1. Agammaglobulinemia
2. Pedigree demonstrating a sex-linked recessive condition characterized by draining ears, eczematoid dermatitis and bloody diarrhea
3. Agammaglobulinamie und alymphozytose mit schwund des lymphatischen gewebes
4. Un exemple d'agammaglobulinemie atypique (un cas de grande hypogammaglobulinemie avec augmentation de la β2 macroglobuline)
5. Recurrent bacterial infections and dysgammaglobulinemia, deficiency of 7S gamma-globulins in the presence of elevated 19S gamma-globulins. Report of two cases
6. Hypergammaglobulinemia associated with severe, recurrent and chronic non-specific infection
7. Immunological function of the thymus
8. Effect of neonatal thymectomy on the immunological responsiveness of the mouse
9. The role of the thymus in development of immunologic capacity in rabbits and mice
10. The bursa of Fabricius and antibody production
11. Developmental immunology and the immunodeficiency diseases
12. Delineation of the thymic and bursal lymphoid systems in the chicken
13. Discussion of Cooper et al.
14. Role of the thymus and other central lymphoid tissues in immunological disease
15. Protection of phagocytized bacteria from the killing action of antibiotics
16. Immunodeficiency diseases caused by defects in phagocytes
17. Identification of IgE-antibodies as a carrier of reaginic activity
18. Extreme hyperimmunoglobulinemia E and undue susceptibility to infection
19. The hyper-IgE syndrome
20. Hyper-IgE syndrome with recurrent infections - An autosomal dominant multisystem disorder
21. Quantitative determination of serum immunoglobulins in antibody-agar plates
22. Serum immunoglobulins II. Levels in children subject to repeated infection
23. Beta-2A aglobulinemia in two healthy men
24. Immunoglobulin spots on the surface of rabbit lymphocytes
25. Membrane receptors and in vitro lymphocyte responsiveness in immunodeficiency
26. Continuous cultures of fused cells secreting antibody of predefined specificity
27. Classification of primary immunodeficiencies
28. Delayed separation of the umbilical cord, widespread infections, and defective neutrophil mobility
29. Inherited deficiency of the Mac-1, LFA-1, p150,95 glycoprotein family and its molecular basis
30. Primary immunodeficiency diseases. Report of an IUIS Scientific Committee
31. Primary immunodeficiency diseases due to defects in lymphocytes
32. Searching for genes involved in the pathogenesis of primary immunodeficiency diseases: Lessons from mouse knockouts
33. The glycoprotein encoded by the X-linked chronic granulomatous disease locus is a component of the neutrophil cytochrome b complex
34. Sequence-based analysis of properdin deficiency, identification of point mutations in two phenotypic forms of an x-linked immunodeficiency
35. IPEX is a unique X-linked syndrome characterized by immune dysfunction, polyendocrinopathy, enteropathy, and a variety of autoimmune phenomena
36. JM2, encoding a fork head-related protein, is mutated in x-linked autoimmunity-allergic disregulation syndrome
37. Leukocyte adhesion deficiency: Molecular basis and functional consequences
38. Adhesion molecule deficiencies and their clinical significance
39. Immunodeficiency diseases due to deficiency of adenosine deaminase
40. Purine nucleoside phosphorylase deficiency
41. A single ataxia telangiectasia gene with a product similar to PI-3 kinase
42. Cloning a balanced translocation associated with DiGeorge syndrome and identification of a disrupted candidate gene
43. A common region of 10p deleted in DiGeorge and velocardiofacial syndromes
44. A transcription map of the DiGeorge and velo-cardio-facial syndrome minimal critical region on 22q11
45. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients
46. Molecular basis of major histocompatibility complex class II deficiency
47. Severe combined immunodeficiency due to a defect in the tyrosine kinase ZAP-70
48. Mutation of Jak3 in a patient with SCID. Essential role of Jak3 in lymphoid development
49. +) severe combined immunodeficiency
50. Recombination defects
51. A new gene involved in DNA double-strand break repair and V(D)J recombination is located on human chromosome 10p
52. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2)
53. Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome
54. Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection
55. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection
56. Primary immunodeficiency mutation databases
57. Circulating B-cells in patients with immunodeficiency
58. Hereditary alterations in the immune response: Coexistence of agammaglobulinemia, acquired hypogammaglobulinemia and selective immunoglobulin deficiency in a sibship
59. Alterations of the X-linked lymphoproliferative disease gene SH2DLA in common variable immunodeficiency syndrome
60. HLA antigens in primary immunodeficiency diseases
61. Individuals with IgA deficiency and common variable immunodeficiency share complex polymorphisms of major histocompatibility complex class III genes
62. Evidence for a defect in 'switch' T cells in patients with immunodeficiency and hyperimmunoglobulinemia M
63. Mapping of the X-linked form of hyper IgM syndrome (HIGM1) to Xq26 by dose linkage to HPRT
64. CD40 ligand gene defects responsible for X-linked hyper IgM syndrome
65. Defective expression of T cell CD40 ligand causes X-linked immunodeficiency with hyper IgM
66. CD40 ligand mutations in X-linked immunodeficiency with hyper IgM
67. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper IgM syndrome
68. A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells
69. Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia
70. Hyper IgM syndrome associated with defective CD40-mediated B cell activation
71. Immunodeficiency with hyperimmunoglobulinemia M in two female patients is not associated with abnormalities of CD40 or CD40 ligand expression
72. Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM
73. Human severe combined immunodeficiency (SCID): Genetic, phenotypic and functional diversity in 108 infants
74. Hematopoietic stem cell transplantation for the treatment of severe combined immunodeficiency
75. Essentielle lymphocytophtose. Ein neues krankeitsbild aus der sauglingspathologie
76. A severe combined immunodeficiency mutation in the mouse
77. Adenosine deaminase deficiency in two patients with severely impaired cellular immunity
78. Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans
79. The interleukin-2 receptor gamma chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDX 1
80. Severe combined immunodeficiency: A retrospective single-center study of clinical presentation and outcome in 117 cases
81. Thymic function after hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency
82. Natural and engineered disorders of lymphocyte development
83. Blood leukocyte values: Man
84. Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival
85. Adenosine deaminase deficiency: Molecular basis and recent developments
86. Interleukin-2 receptor gamma chain: A functional component of the interleukin-7 receptor
87. RAG mutations in human B cell-negative SCID
88. Mutations in the tyrosine phosphatase CD45 gene in a child with severe combined immunodeficiency disease
89. Adult onset immunodeficiency caused by inherited adenosine deaminase deficiency
90. The interleukin-2 receptor gamma chain: Its role in the multiple cytokine receptor complexes and T cell development in XSCID
91. Cutting edge: The common gamma-chain is an indispensable subunit of the IL-21 receptor complex
92. The interleukin-2 receptor gamma chain: Its role in the multiple cytokine receptor complexes and T cell development in XSCID
93. Mutation analysis of IL2RG in human X-linked severe combined immunodeficiency
94. Interleukin-2 receptor gamma chain: A functional component of the interleukin-4 receptor
95. Atypical X-linked severe combined immunodeficiency due to possible spontaneous reversion of the genetic defect in T cells
96. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID)
97. Of genes and phenotypes: The immunological and molecular spectrum of combined immune deficiency. Defects of the gamma(c) -JAK3 signaling pathway as a model
98. Partial V (D) J recombination activity leads to Omenn syndrome
99. Highly restricted human T cell repertoire in peripheral blood and tissue-infiltrating lymphocytes in Omenn's syndrome
100. T-cell receptor analysis in Omenn's syndrome, evidence for defects in gene rearrangement and assembly
101. The lymph node pathology of Omenn's syndrome
102. A human severe combined immunodeficiency (SCID) condition with increased sensitivity to ionizing radiations and impaired V (D) J rearrangements defines a new DNA recombination/repair deficiency
103. A deletion in the gene encoding the CD45 antigen in a patient with SCID
104. Plasma therapy in immunodeficiency disease
105. Plasma infusions in immunologic deficiency states. Metabolic and therapeutic studies
106. Use of intravenous gamma-globulin in antibody immunodeficiency: Results of a multicenter controlled trial
107. The use of intravenous immunoglobulin in immunodeficiency diseases
108. Hu-1: Major histocompatibility locus in man
109. Immunological reconstitution of sex-linked lymphopenic immunological deficiency
110. Bone marrow transplantation in a patient with the Wiskott-Aldrich syndrome
111. Selective immunoglobulin deficiency associated with thymic alymphoplasia
112. 25th anniversary for the first successful allogeneic bone marrow transplants
113. Severe combined immunodeficiency disease. Characterization of the disease and results of transplantation
114. Bone marrow transplantation in rats across strong histocompatibility barriers by selective elimination of lymphoid cells in donor marrow
115. Hematopoietic stem cell transplantation using mouse bone marrow and spleen cells fractionated by lectins
116. Transplantation for severe combined immunodeficiency with HLA-A, B, D, DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells
117. Advances in the understanding and treatment of human severe combined immunodeficiency
118. Studies of human bone marrow treated with soybean lectin and sheep erythrocytes: Stepwise analysis of cell morphology, phenotype and function
119. Neonatal bone marrow transplantation for severe combined immunodeficiency
120. Modified MHC restriction of donor-origin T cells in humans with severe combined immunodeficiency transplanted with haploidentical bone marrow stem cells
121. Modified responses to recipient and donor B cells by genetically donor T cells from human haploidentical bone marrow chimeras
122. Gene therapy for immunodeficiency
123. The potential for therapy of immune disorders with gene therapy
124. Gene therapy for human severe combined immunodeficiencies
125. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy
126. Gene therapy of human severe combined immunodeficiency (SCID) -X1 disease